
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Landos Biopharma
Landos Biopharma, Inc. operates as a pharmaceutical company. The Company discovers and develops oral therapeutics for patients with autoimmune diseases. Landos Biopharma serves customers worldwide.
Stock Analysis

last close
$0.73
1-mo return
0.2%
3-mo return
-50.7%
avg daily vol.
124.43T
52-week high
16.17
52-week low
0.55
market cap.
$25M
forward pe
-
annual div.
-
roe
-53.2%
ltg forecast
-
dividend yield
-
annual rev.
$18M
inst own.
64.1%